Affordable Access

Activity of bevacizumab (rhuMAB VEGF) in advanced refractory epithelial ovarian cancer.

Authors
Type
Published Article
Journal
Gynecologic oncology
Publication Date
Volume
96
Issue
3
Pages
902–905
Identifiers
PMID: 15721449
Source
Medline

Abstract

Bevacizumab has activity in epithelial ovarian carcinoma and larger scale trials are indicated.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments